These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35496788)

  • 1. Protocol for isolation and analysis of small volatile microbiome metabolites from human or mouse samples.
    Bell HN; Das NK; Shah YM
    STAR Protoc; 2022 Jun; 3(2):101311. PubMed ID: 35496788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders.
    Luan H; Wang X; Cai Z
    Mass Spectrom Rev; 2019 Jan; 38(1):22-33. PubMed ID: 29130504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized protocol to isolate primary mouse peritoneal macrophage metabolites.
    De Jesus A; Pusec CM; Nguyen T; Keyhani-Nejad F; Gao P; Weinberg SE; Ardehali H
    STAR Protoc; 2022 Dec; 3(4):101668. PubMed ID: 36103306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for studying microbiome impact on host energy and reproduction in
    Gnainsky Y; Itkin M; Mehlman T; Brandis A; Malitsky S; Soen Y
    STAR Protoc; 2022 Jun; 3(2):101253. PubMed ID: 35330965
    [No Abstract]   [Full Text] [Related]  

  • 5. Protocol for correlation analysis of the murine gut microbiome and meta-metabolome using 16S rDNA sequencing and UPLC-MS.
    Li X; Wu P; Zeng X; Lang Q; Lin Y; Huang H; Qian P
    STAR Protoc; 2022 Sep; 3(3):101494. PubMed ID: 35776638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of gut microbiota fecal metabolites by chromatographic targeted approaches.
    Fiori J; Turroni S; Candela M; Gotti R
    J Pharm Biomed Anal; 2020 Jan; 177():112867. PubMed ID: 31614303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted metabolomics for the quantitative measurement of 9 gut microbiota-host co-metabolites in rat serum, urine and feces by liquid chromatography-tandem mass spectrometry.
    Zeng Y; Lin Y; Li L; Li Y; Zhang X; Wang M; Chen Y; Luo L; Lu B; Xie Z; Liao Q
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1110-1111():133-143. PubMed ID: 30807966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol for analysis of liquid chromatography-mass spectrometry metabolomics data using R to understand how metabolites affect disease.
    Lin H; Hu C; Wang S; Xu Y; Xu M; Bi Y; Lu J
    STAR Protoc; 2023 Mar; 4(1):102137. PubMed ID: 36861827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assay to detect bacterial glycan-degrading enzyme activities in mouse and human fecal samples.
    Steimle A; Grant ET; Desai MS
    STAR Protoc; 2021 Mar; 2(1):100326. PubMed ID: 33665621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A strategy for the targeted metabolomics analysis of 11 gut microbiota-host co-metabolites in rat serum, urine and feces by ultra high performance liquid chromatography-tandem mass spectrometry.
    Hou W; Zhong D; Zhang P; Li Y; Lin M; Liu G; Yao M; Liao Q; Xie Z
    J Chromatogr A; 2016 Jan; 1429():207-17. PubMed ID: 26733392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Profiling of Fecal Metabolome of Mice by Integrated Chemical Isotope Labeling-Mass Spectrometry Analysis.
    Yuan BF; Zhu QF; Guo N; Zheng SJ; Wang YL; Wang J; Xu J; Liu SJ; He K; Hu T; Zheng YW; Xu FQ; Feng YQ
    Anal Chem; 2018 Mar; 90(5):3512-3520. PubMed ID: 29406693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global profiling of gut microbiota-associated lipid metabolites in antibiotic-treated mice by LC-MS/MS-based analyses.
    Okahashi N; Ueda M; Yasuda S; Tsugawa H; Arita M
    STAR Protoc; 2021 Jun; 2(2):100492. PubMed ID: 33997812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of lincosamides antibiotics on the composition of the rat gut microbiota and the metabolite profile of plasma and feces.
    Behr C; Ramírez-Hincapié S; Cameron HJ; Strauss V; Walk T; Herold M; Beekmann K; Rietjens IMCM; van Ravenzwaay B
    Toxicol Lett; 2018 Oct; 296():139-151. PubMed ID: 30102961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome.
    Xu W; Chen D; Wang N; Zhang T; Zhou R; Huan T; Lu Y; Su X; Xie Q; Li L; Li L
    Anal Chem; 2015 Jan; 87(2):829-36. PubMed ID: 25486321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocol for isolation of microbiota-derived membrane vesicles from mouse blood and colon.
    Erttmann SF; Gekara NO
    STAR Protoc; 2023 Mar; 4(1):102046. PubMed ID: 36853709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges of metabolomics in human gut microbiota research.
    Smirnov KS; Maier TV; Walker A; Heinzmann SS; Forcisi S; Martinez I; Walter J; Schmitt-Kopplin P
    Int J Med Microbiol; 2016 Aug; 306(5):266-279. PubMed ID: 27012595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatially resolved sampling of the human oral cavity for metabolic profiling.
    Ciurli A; Derks RJE; Liebl M; Ammon C; Neefjes J; Giera M
    STAR Protoc; 2021 Dec; 2(4):101002. PubMed ID: 34917980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for preparation and measurement of intracellular and extracellular modified RNA using liquid chromatography-mass spectrometry.
    Ogawa A; Wei FY
    STAR Protoc; 2021 Dec; 2(4):100848. PubMed ID: 34622220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive mass spectrometric analysis of carbonyl metabolites in human urine and fecal samples using chemoselective modification.
    Lin W; Conway LP; Block A; Sommi G; Vujasinovic M; Löhr JM; Globisch D
    Analyst; 2020 Jun; 145(11):3822-3831. PubMed ID: 32393929
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.